Accesso libero

Virtual modelling of novel applicator prototypes for cervical cancer brachytherapy

Primoz Petric

Primoz Petric

Cerca questo autore su
Sciendo|Google Scholar
Petric, Primoz
, 
Robert Hudej

Robert Hudej

Cerca questo autore su
Sciendo|Google Scholar
Hudej, Robert
, 
Noora Al-Hammadi

Noora Al-Hammadi

Cerca questo autore su
Sciendo|Google Scholar
Al-Hammadi, Noora
 e 
Barbara Segedin

Barbara Segedin

Cerca questo autore su
Sciendo|Google Scholar
Segedin, Barbara
  
09 nov 2016
Virtual modelling of novel applicator prototypes for cervical cancer brachytherapy's Cover Image
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Cita
Scarica la copertina
Categoria dell'articolo: Research Article
Pubblicato online: 09 nov 2016
Pagine: 433 - 441
Ricevuto: 01 lug 2016
Accettato: 29 ago 2016
DOI: https://doi.org/10.1515/raon-2016-0048
Parole chiave
© 2016 Radiol Oncol
This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Principles of Target-volume Density Map (TDM) generation and postprocessing on an example of 6 cervical cancer cases. (A) Contours of high risk clinical target volumes (CTVHR – thin white lines) are shown on mid-coronal T2 weighted MRI with the applicator in place. Source channels are depicted as thick white lines. (B) CAT 2 generates the TDM by rigid co-registration of individual CTVHRs on a reference applicator. TDM voxels are assigned target density values, corresponding to the number of encompassing CTVHRs. These values are transformed to grey levels. (C) Resulting TDM DICOM image is exported to treatment planning system where isodensity contours (IDC) are auto-segmented (white dotted lines).
Principles of Target-volume Density Map (TDM) generation and postprocessing on an example of 6 cervical cancer cases. (A) Contours of high risk clinical target volumes (CTVHR – thin white lines) are shown on mid-coronal T2 weighted MRI with the applicator in place. Source channels are depicted as thick white lines. (B) CAT 2 generates the TDM by rigid co-registration of individual CTVHRs on a reference applicator. TDM voxels are assigned target density values, corresponding to the number of encompassing CTVHRs. These values are transformed to grey levels. (C) Resulting TDM DICOM image is exported to treatment planning system where isodensity contours (IDC) are auto-segmented (white dotted lines).
Schematic representation of applicator modelling based on our theoretical example of Target-volume Density Map (TDM). Above: Three virtual applicators are reconstructed on the TDM. Dose distribution is optimized based on a set of specific planning aims for the isodensity contours (IDC) and for residual volumes at risk (RVR). The optimized prescription isodoses for individual applicators are shown as thick dotted lines. (A) Standard intracavitary applicator: limited possibility for optimization. The planning aim is achieved for ≈70% IDC. (B) Combined intracavitary and interstitial applicator with parallel parametrial needles (Vienna-type): planning aim is achieved for ≈95% IDC. (C) Combined intracavitary and interstitial applicator with parallel and oblique parametrial needles: planning aim as achieved for ≈100 % IDC. (D) Characteristic curves for the IDC of the three applicator types. RVR curves are not shown. Shaded areas under characteristic curves represents IDC ranges in which certain applicator is able to achieve the planning aim. Arbitrary planning aim and applicator thresholds are marked by dotted lines.
Schematic representation of applicator modelling based on our theoretical example of Target-volume Density Map (TDM). Above: Three virtual applicators are reconstructed on the TDM. Dose distribution is optimized based on a set of specific planning aims for the isodensity contours (IDC) and for residual volumes at risk (RVR). The optimized prescription isodoses for individual applicators are shown as thick dotted lines. (A) Standard intracavitary applicator: limited possibility for optimization. The planning aim is achieved for ≈70% IDC. (B) Combined intracavitary and interstitial applicator with parallel parametrial needles (Vienna-type): planning aim is achieved for ≈95% IDC. (C) Combined intracavitary and interstitial applicator with parallel and oblique parametrial needles: planning aim as achieved for ≈100 % IDC. (D) Characteristic curves for the IDC of the three applicator types. RVR curves are not shown. Shaded areas under characteristic curves represents IDC ranges in which certain applicator is able to achieve the planning aim. Arbitrary planning aim and applicator thresholds are marked by dotted lines.
Lingua:
Inglese
Frequenza di pubblicazione:
4 volte all'anno
Argomenti della rivista:
Medicina, Medicina clinica, Medicina interna, Ematologia, Oncologia, Radiologia
Feed RSS della rivista